These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30045138)

  • 1. Changes in the Management and Prognosis of Ovarian Cancer Due to the New FIGO and WHO Classifications: A Case Series Observational Descriptive Study. Seven Years of Follow-up.
    Gomes Ferreira M; Sancho de Salas M; González Sarmiento R; Doyague Sánchez MJ
    Int J Gynecol Cancer; 2018 Oct; 28(8):1461-1470. PubMed ID: 30045138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum].
    Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V
    Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer.
    Zeppernick F; Meinhold-Heerlein I
    Arch Gynecol Obstet; 2014 Nov; 290(5):839-42. PubMed ID: 25082067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma.
    Yamagami W; Nagase S; Takahashi F; Ino K; Hachisuga T; Mikami M; Enomoto T; Katabuchi H; Aoki D
    J Gynecol Oncol; 2020 Jul; 31(4):e45. PubMed ID: 32026659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
    Rosendahl M; Høgdall CK; Mosgaard BJ
    Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer.
    Matsuo K; Bond VK; Eno ML; Im DD; Rosenshein NB
    Int J Cancer; 2009 Dec; 125(11):2721-7. PubMed ID: 19530239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma.
    Kuhn W; Rutke S; Späthe K; Schmalfeldt B; Florack G; von Hundelshausen B; Pachyn D; Ulm K; Graeff H
    Cancer; 2001 Nov; 92(10):2585-91. PubMed ID: 11745193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
    Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy.
    Rodriguez N; Rauh-Hain JA; Shoni M; Berkowitz RS; Muto MG; Feltmate C; Schorge JO; Del Carmen MG; Matulonis UA; Horowitz NS
    Gynecol Oncol; 2012 May; 125(2):362-6. PubMed ID: 22333992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Revised FIGO Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum Based on a Single Histological Type.
    Toptas T; Pestereli E; Erol O; Bozkurt S; Erdogan G; Simsek T
    Int J Gynecol Cancer; 2016 Jul; 26(6):1012-9. PubMed ID: 27206284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Third National Ovarian Consensus. 2011. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México "GICOM"].
    Gallardo-Rincón D; Cantú-de-León D; Alanís-López P; Alvarez-Avitia MA; Bañuelos-Flores J; Herbert-Núñez GS; Oñate-Ocaña LF; Pérez-Montiel MD; Rodríguez-Trejo A; Ruvalcaba-Limón E; Serrano-Olvera A; Ortega-Rojo A; Cortés-Esteban P; Erazo-Valle A; Gerson-Cwilich R; De-la-Garza-Salazar J; Green-Renner D; León-Rodríguez E; Morales-Vásquez F; Poveda-Velasco A; Aguilar-Ponce JL; Alva-López LF; Alvarado-Aguilar S; Alvarado-Cabrero I; Aquino-Mendoza CA; Aranda-Flores CE; Bandera-Delgado A; Barragán-Curiel E; Barrón-Rodríguez P; Brom-Valladares R; Cabrera-Galeana PA; Calderillo-Ruiz G; Camacho-Gutiérrez S; Capdeville-García D; Cárdenas-Sánchez J; Carlón-Zárate E; Carrillo-Garibaldi O; Castorena-Roji G; Cervantes-Sánchez G; Coronel-Martínez JA; Chanona-Vilchis JG; Díaz-Hernández V; Escudero-de-los Ríos P; Garibay-Cerdenares O; Gómez-García E; Herrera-Montalvo LA; Hinojosa-García LM; Isla-Ortiz D; Jiménez-López J; Lavín-Lozano AJ; Limón-Rodriguez JA; López-Basave HN; López-García SC; Maffuz-Aziz A; Martínez-Cedillo J; Martínez-López DM; Medina-Castro JM; Melo-Martínez C; Méndez-Herrera C; Montalvo-Esquivel G; Morales-Palomares MA; Morán-Mendoza A; Morgan-Villela G; Mota-García A; Muñoz-González DE; Ochoa-Carrillo FJ; Pérez-Amador M; Recinos-Money E; Rivera-Rivera S; Robles Flores JU; Rojas-Castillo E; Rojas-Marín C; Salas-Gonzáles E; Sámano-Nateras L; Santibañez-Andrade M; Santillán-Gómez A; Silva-García A; Silva JA; Solorza-Luna G; Tabarez-Ortiz AR; Talamás-Rohana P; Tirado-Gómez LL; Torres-Lobatón A; Quijano-Castro F
    Rev Invest Clin; 2011; 63(6):665-702. PubMed ID: 23650680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy with carboplatin and taxane compared with single drug carboplatin in early stage epithelial ovarian carcinoma.
    Skírnisdóttir I; Lindborg K; Sorbe B
    Oncol Rep; 2007 Nov; 18(5):1249-56. PubMed ID: 17914581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of early-stage primary serous fallopian tube carcinomas and equivalent stage serous epithelial ovarian carcinomas.
    Horng HC; Lai CR; Chang WH; Wen KC; Chen YJ; Juang CM; Yen MS; Wang PH
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):547-51. PubMed ID: 25510699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade epithelial ovarian cancer: what a radiologist should know.
    Elsherif S; Javadi S; Viswanathan C; Faria S; Bhosale P
    Br J Radiol; 2019 Mar; 92(1095):20180571. PubMed ID: 30604635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.
    Eitan R; Levine DA; Abu-Rustum N; Sonoda Y; Huh JN; Franklin CC; Stevens TA; Barakat RR; Chi DS
    Cancer; 2005 Apr; 103(7):1397-401. PubMed ID: 15726548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison Of Early-Stage High-Grade Serous Primary Fallopian Tube Cancers and Epithelial Ovarian Cancers: A Multicenter Study.
    Gungorduk K; Ozdemir A; Selcuk I; Telli E; Şahin Ö; Toptaş T; Akman L; Güzel AB; Taşkın S; Öge T; Güngördük Ö; Gokçü M; Gungor T; Yaşar L; Terek MC; Ozan H; Ozsaran A; Sancı M; Vardar MA; Meydanlı MM; Yalçın ÖT; Ortac F; Özalp S
    Oncol Res Treat; 2017; 40(4):203-206. PubMed ID: 28376498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors for survival of ovarian epithelial cancers: apropos of 287 cases].
    Brun JL; Bouzigon E; Saurel J; Chêne G; Briex M; Brun G; Hocke C
    Gynecol Obstet Fertil; 2000 Mar; 28(3):223-31. PubMed ID: 10786403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCAD.
    Chekerov R; Braicu I; Castillo-Tong DC; Richter R; Cadron I; Mahner S; Woelber L; Marth C; Van Gorp T; Speiser P; Zeillinger R; Vergote I; Sehouli J
    Int J Gynecol Cancer; 2013 Feb; 23(2):268-75. PubMed ID: 23358178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Staging of Ovarian Cancer.
    O'Shea AS
    Methods Mol Biol; 2022; 2424():3-10. PubMed ID: 34918284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.